Mometasone furoate
[(8S,9R,10S,11S,13S,14S,16R,17R)-9-Chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
Drag to rotate. Structure from PubChem CID 441336.
Background
Listing
- Schedules
- Schedule 2 to 4, conditions apply
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
7 registered products listed
Counted through the register's ingredient index, which does not reach every record.
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Mometasone furoate, orbifloxacin, posaconazole | Posatex | Not stated | Intervet South Africa (Pty) Ltd | 14-Dec | S2 to S4conditions apply |
| Florfenicol, mometasone furoate, terbinafine | Neptra ear | drops | Elanco Animal Health (Pty) Ltd | 20/06 | S1 to S4conditions apply |
| Mometasone furoate | Elica, Elomet, Nasonex, +16 more | cream, ointment, lotion, 0,1 %, +6 more | 9 applicants | 26 registrations | S4 |
| Formoterol, mometasone furoate | Dulera | 50/5 mcg, 100/5 mcg, 200/5 mcg | Organon South Africa (Pty) Ltd | 3 registrations | S2 to S4conditions apply |
| Azelastine, mometasone furoate | Astinasil ns | 50/140 | Forrester Pharma (Pty) Ltd | 500481 | S2 to S4conditions apply |
| Indacaterol, mometasone furoate | Atectura breezhaler, Bemrist breezhaler | 80_g, 150_g, 160_g, 320_g | Novartis South Africa (Pty) Ltd | 6 registrations | S2 to S4conditions apply |
| Glycopyrronium, indacaterol, mometasone furoate | Enerzair breezhaler, Zimbus breezhaler | 150/50/80, 150/50/160 | Novartis South Africa (Pty) Ltd | 4 registrations | S2 to S4conditions apply |
1 more registered product name Mometasone furoate in their active ingredient
| Name | Brands | Dosages | Applicants | Registrations | Schedule |
|---|---|---|---|---|---|
| Mometasone furoate, olopatadine | Ryaltris | Not stated | Glenmark Pharmaceuticals South Africa (Pty) Ltd | 530457 |
Regulatory status
Where S2 to S4 sits on the scale
Depends on which listing applies
At the least restrictive, Schedule 2: a pharmacist can sell it directly, without a prescription. At the most restrictive, Schedule 4: prescription-only medicine. The listings below say which applies to which form, strength or pack size.
Schedule S2 to S4, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Mometasone furoate
S4: Mometasone furoate
- except when intended for inhalation or nasal administration.
Consolidated Schedules 06 July 2026, line 7167
S3: Mometasone furoate
- when intended for inhalation or nasal administration, except when intended for nasal administration as an aqueous spray, other than by pressurized aerosol, and indicated for the treatment of the symptoms of seasonal or perennial allergic rhinitis (hay fever) in adults and children between the age of 2 and 11 years of age, subject to
- when a maximum dose of 200 micrograms per nostril in adults and 50 micrograms per nostril in children; and
- when a maximum pack size of 200 doses. (S2, S4)
Consolidated Schedules 06 July 2026, lines 3960 to 3965
S2: Mometasone furoate
- when intended for nasal administration as an aqueous spray, other than by pressurized aerosol, and indicated for the treatment of the symptoms of seasonal or perennial allergic rhinitis (hay fever) in adults and children between the age of 2 and 11 years of age, subject to
- when a maximum dose of 200 micrograms per nostril in adults and 50 micrograms per nostril in children; and
- when a maximum pack size of 200 doses. (S3, S4)
Consolidated Schedules 06 July 2026, lines 2284 to 2290
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.